SAIPAN – The Commonwealth Healthcare Corporation has maintained its federal Clinical Laboratory Improvement Amendments (CLIA) certification for all three island laboratories in Saipan, Tinian, and Rota following a biennial CMS survey, securing uninterrupted diagnostic services across the CNMI. A biennial CMS survey is the every-two-years inspection required under federal CLIA rules to ensure labs meet national quality and patient-safety standards.
CHCC said keeping CLIA certification is essential for legal compliance, diagnostic accuracy, and patient safety, underpinning clinical decision-making, disease prevention, and rapid emergency response throughout the Commonwealth. Without certification, the labs would lose authority to perform or bill for testing, forcing specimens off-island and risking delays in outbreaks, trauma, or critical care cases. The recertification guarantees 24/7 operations while CHCC serves as both the hospital system and public health authority.
The renewal also positions Rota and Tinian to expand on-island testing and handle higher-complexity diagnostics, reducing dependence on Saipan, speeding clinical decisions, and strengthening the resiliency and equity of the lab network. Certification enables reimbursement from Medicare, Medicaid, and private insurers, bolstering CHCC’s fiscal stability and credibility with regulators, accreditors, and partners such as the CDC, and supports continued federal funding and regional collaborations. CHCC noted the CLIA framework advances workforce sustainability through competency assessments, continuing education, and quality assurance that align with building a locally trained, compliant lab workforce. Overall, leaders framed the recertification as a cornerstone of care quality, ensuring timely, reliable results while sustaining operations and capacity for communities across Saipan, Rota, and Tinian.
